Affiliation:
1. Unité de Bactériologie Médicale, Institut Pasteur, 75724 Paris
2. Centre de Recherches Roussel-Uclaf, 93230 Romainville, France
Abstract
HR 756, the
syn
derivative of 7-[(2-(2-amino-4-thiazolyl)-2-methoxyimino)acetamido]cephalosporanic acid, is a new semisynthetic cephalosporin. It was 80 times more active than the
anti
derivative against β-lactamase-producing strains of gram-negative bacteria. The range of inhibitory concentrations of HR 756 against gram-negative bacteria, including
Haemophilus influenzae
, susceptible or resistant to penicillins and cephalosporins was from 0.01 to 0.1 μg/ml. This activity was consistently higher than those observed with cephalothin, cephaloridine, cephalexin, and cefazolin. Nevertheless, some strains of
Enterobacter cloacae
were resistant. HR 756 showed very similar activity to that of ampicillin against group A streptococci and
Streptococcus pneumoniae
.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献